UDR (NYSE:UDR – Get Free Report) updated its FY24 earnings guidance on Tuesday. The company provided earnings per share guidance of $2.38-$2.50 for the period, compared to the consensus earnings per share estimate of $2.44. UDR also updated its Q2 guidance to $0.60-$0.62 EPS.
UDR Stock Down 0.5 %
UDR stock traded down $0.21 during mid-day trading on Tuesday, reaching $38.08. The company’s stock had a trading volume of 3,263,255 shares, compared to its average volume of 2,945,900. The company has a debt-to-equity ratio of 1.47, a quick ratio of 5.15 and a current ratio of 5.15. The business’s 50 day simple moving average is $36.78 and its 200 day simple moving average is $35.97. The company has a market capitalization of $12.54 billion, a price-to-earnings ratio of 28.55, a price-to-earnings-growth ratio of 3.03 and a beta of 0.80. UDR has a 12 month low of $30.95 and a 12 month high of $44.02.
UDR Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 30th. Stockholders of record on Wednesday, April 10th will be issued a $0.425 dividend. This represents a $1.70 annualized dividend and a dividend yield of 4.46%. The ex-dividend date of this dividend is Tuesday, April 9th. This is an increase from UDR’s previous quarterly dividend of $0.42. UDR’s dividend payout ratio is presently 126.87%.
Wall Street Analyst Weigh In
UDR Company Profile
UDR, Inc (NYSE: UDR), an S&P 500 company, is a leading multifamily real estate investment trust with a demonstrated performance history of delivering superior and dependable returns by successfully managing, buying, selling, developing and redeveloping attractive real estate communities in targeted U.S.
Read More
- Five stocks we like better than UDR
- How to invest in blue chip stocks
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Want to Profit on the Downtrend? Downtrends, Explained.
- Hilton Demonstrates Asset Light is Right for Investors
- Most active stocks: Dollar volume vs share volume
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for UDR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UDR and related companies with MarketBeat.com's FREE daily email newsletter.